| Entry |
|
| Name |
Adenylosuccinate lyase deficiency
|
| Description |
Adenylosuccinate lyase deficiency is an autosomal-recessive disorder of the purine de novo synthesis pathway. Mental retardation is a major manifestation and most patients have seizures.
|
| Category |
Inherited metabolic disease; Nervous system disease
 |
| Pathway |
| Purine metabolism | | Alanine, aspartate and glutamate metabolism |
|
| Gene |
ADSL; adenylosuccinate lyase [HSA: 158] [KO: K01756]
|
| Marker |
Succinyladenosine [CPD: C03794]
Succinylaminoimidazole carboxamide ribotide (SAICAR) [CPD: C04823]
|
| Drug |
|
| Other DBs |
|
| Reference |
|
| Authors |
Spiegel EK, Colman RF, Patterson D |
| Title |
Adenylosuccinate lyase deficiency. |
| Journal |
Mol Genet Metab 89:19-31 (2006) |
| Reference |
|
| Authors |
Ciardo F, Salerno C, Curatolo P |
| Title |
Neurologic aspects of adenylosuccinate lyase deficiency. |
| Journal |
J Child Neurol 16:301-8 (2001) |
| Reference |
|
| Authors |
Nassogne M, Henrot B, Aubert G, Bonnier C, Marie S, Saint-Martin C, Van den Berghe G, Sebire G, Vincent M |
| Title |
Adenylosuccinase deficiency: an unusual cause of early-onset epilepsy associated with acquired microcephaly. |
| Journal |
Brain Dev 22:383-6 (2000) |